Trial of management of borderline and other low grade abnormal smears (TOMBOLA)

Trial design

Seonaidh Claire Cotton (Corresponding Author), Linda Sharp, Julian Little, Margaret Eleanor Cruickshank, The TOMBOLA (Trial Of Management of Borderline and Other Low-grade Abnormal smears) Group

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Cervical screening reduces the risk of cervical cancer by detecting and treating cervical intraepithelial neoplasia (CIN). The management of women with low-grade cervical abnormalities is controversial. Two management policies exist: repeat smears in primary care and colposcopy examination. It is not clear which of these is the more effective and efficient. There is also uncertainty as to the most effective and efficient management of women at colposcopy when an area of abnormality is seen on the cervix - immediate treatment or biopsy and selective recall for treatment if the biopsy result suggests this is necessary. The result of a human papillomavirus (HPV) test might assist in deciding the appropriate management of women with low-grade abnormalities. TOMBOLA, a pragmatic randomised-controlled trial set within the cervical screening programmes in Scotland and England, addresses these three arm of uncertainty. Almost four and a half thousand women aged 20-59 with a low-grade cervical abnormality have been recruited and randomised to either repeat smears or colposcopy examination. Women in the colposcopy arm of the trial are further randomised to a policy of either immediate treatment or biopsy and selective recall for treatment if they have an abnormal transformation zone. Women are followed up to an exit examination at 3 years. HPV testing is undertaken at recruitment and at the exit examination. The primary endpoint is cumulative incidence of CIN2/3. A range of other clinical, psychosocial and economic outcomes is being considered. This paper describes the design of the trial, and discusses the rationale underlying aspects of the design and the challenges faced in designing and implementing the trial. (c) 2006 Elsevier Inc. All rights reserved.

Original languageEnglish
Pages (from-to)449-471
Number of pages23
JournalContemporary Clinical Trials
Volume27
Issue number5
DOIs
Publication statusPublished - Oct 2006

Keywords

  • randomised controlled trial
  • cervical screening
  • colposcopy
  • cytological surveillance
  • management
  • low-grade abnormalities
  • cervix uteri
  • mild dyskaryosis

Cite this

Trial of management of borderline and other low grade abnormal smears (TOMBOLA) : Trial design. / Cotton, Seonaidh Claire (Corresponding Author); Sharp, Linda; Little, Julian; Cruickshank, Margaret Eleanor; The TOMBOLA (Trial Of Management of Borderline and Other Low-grade Abnormal smears) Group.

In: Contemporary Clinical Trials, Vol. 27, No. 5, 10.2006, p. 449-471.

Research output: Contribution to journalArticle

Cotton, SC, Sharp, L, Little, J, Cruickshank, ME & The TOMBOLA (Trial Of Management of Borderline and Other Low-grade Abnormal smears) Group 2006, 'Trial of management of borderline and other low grade abnormal smears (TOMBOLA): Trial design', Contemporary Clinical Trials, vol. 27, no. 5, pp. 449-471. https://doi.org/10.1016/j.cct.2006.04.001
Cotton, Seonaidh Claire ; Sharp, Linda ; Little, Julian ; Cruickshank, Margaret Eleanor ; The TOMBOLA (Trial Of Management of Borderline and Other Low-grade Abnormal smears) Group. / Trial of management of borderline and other low grade abnormal smears (TOMBOLA) : Trial design. In: Contemporary Clinical Trials. 2006 ; Vol. 27, No. 5. pp. 449-471.
@article{42df0c0c8d2a467fb4a19aebdbc6690e,
title = "Trial of management of borderline and other low grade abnormal smears (TOMBOLA): Trial design",
abstract = "Cervical screening reduces the risk of cervical cancer by detecting and treating cervical intraepithelial neoplasia (CIN). The management of women with low-grade cervical abnormalities is controversial. Two management policies exist: repeat smears in primary care and colposcopy examination. It is not clear which of these is the more effective and efficient. There is also uncertainty as to the most effective and efficient management of women at colposcopy when an area of abnormality is seen on the cervix - immediate treatment or biopsy and selective recall for treatment if the biopsy result suggests this is necessary. The result of a human papillomavirus (HPV) test might assist in deciding the appropriate management of women with low-grade abnormalities. TOMBOLA, a pragmatic randomised-controlled trial set within the cervical screening programmes in Scotland and England, addresses these three arm of uncertainty. Almost four and a half thousand women aged 20-59 with a low-grade cervical abnormality have been recruited and randomised to either repeat smears or colposcopy examination. Women in the colposcopy arm of the trial are further randomised to a policy of either immediate treatment or biopsy and selective recall for treatment if they have an abnormal transformation zone. Women are followed up to an exit examination at 3 years. HPV testing is undertaken at recruitment and at the exit examination. The primary endpoint is cumulative incidence of CIN2/3. A range of other clinical, psychosocial and economic outcomes is being considered. This paper describes the design of the trial, and discusses the rationale underlying aspects of the design and the challenges faced in designing and implementing the trial. (c) 2006 Elsevier Inc. All rights reserved.",
keywords = "randomised controlled trial, cervical screening, colposcopy, cytological surveillance, management, low-grade abnormalities, cervix uteri, mild dyskaryosis",
author = "Cotton, {Seonaidh Claire} and Linda Sharp and Julian Little and Cruickshank, {Margaret Eleanor} and {The TOMBOLA (Trial Of Management of Borderline and Other Low-grade Abnormal smears) Group}",
year = "2006",
month = "10",
doi = "10.1016/j.cct.2006.04.001",
language = "English",
volume = "27",
pages = "449--471",
journal = "Contemporary Clinical Trials",
issn = "1551-7144",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Trial of management of borderline and other low grade abnormal smears (TOMBOLA)

T2 - Trial design

AU - Cotton, Seonaidh Claire

AU - Sharp, Linda

AU - Little, Julian

AU - Cruickshank, Margaret Eleanor

AU - The TOMBOLA (Trial Of Management of Borderline and Other Low-grade Abnormal smears) Group

PY - 2006/10

Y1 - 2006/10

N2 - Cervical screening reduces the risk of cervical cancer by detecting and treating cervical intraepithelial neoplasia (CIN). The management of women with low-grade cervical abnormalities is controversial. Two management policies exist: repeat smears in primary care and colposcopy examination. It is not clear which of these is the more effective and efficient. There is also uncertainty as to the most effective and efficient management of women at colposcopy when an area of abnormality is seen on the cervix - immediate treatment or biopsy and selective recall for treatment if the biopsy result suggests this is necessary. The result of a human papillomavirus (HPV) test might assist in deciding the appropriate management of women with low-grade abnormalities. TOMBOLA, a pragmatic randomised-controlled trial set within the cervical screening programmes in Scotland and England, addresses these three arm of uncertainty. Almost four and a half thousand women aged 20-59 with a low-grade cervical abnormality have been recruited and randomised to either repeat smears or colposcopy examination. Women in the colposcopy arm of the trial are further randomised to a policy of either immediate treatment or biopsy and selective recall for treatment if they have an abnormal transformation zone. Women are followed up to an exit examination at 3 years. HPV testing is undertaken at recruitment and at the exit examination. The primary endpoint is cumulative incidence of CIN2/3. A range of other clinical, psychosocial and economic outcomes is being considered. This paper describes the design of the trial, and discusses the rationale underlying aspects of the design and the challenges faced in designing and implementing the trial. (c) 2006 Elsevier Inc. All rights reserved.

AB - Cervical screening reduces the risk of cervical cancer by detecting and treating cervical intraepithelial neoplasia (CIN). The management of women with low-grade cervical abnormalities is controversial. Two management policies exist: repeat smears in primary care and colposcopy examination. It is not clear which of these is the more effective and efficient. There is also uncertainty as to the most effective and efficient management of women at colposcopy when an area of abnormality is seen on the cervix - immediate treatment or biopsy and selective recall for treatment if the biopsy result suggests this is necessary. The result of a human papillomavirus (HPV) test might assist in deciding the appropriate management of women with low-grade abnormalities. TOMBOLA, a pragmatic randomised-controlled trial set within the cervical screening programmes in Scotland and England, addresses these three arm of uncertainty. Almost four and a half thousand women aged 20-59 with a low-grade cervical abnormality have been recruited and randomised to either repeat smears or colposcopy examination. Women in the colposcopy arm of the trial are further randomised to a policy of either immediate treatment or biopsy and selective recall for treatment if they have an abnormal transformation zone. Women are followed up to an exit examination at 3 years. HPV testing is undertaken at recruitment and at the exit examination. The primary endpoint is cumulative incidence of CIN2/3. A range of other clinical, psychosocial and economic outcomes is being considered. This paper describes the design of the trial, and discusses the rationale underlying aspects of the design and the challenges faced in designing and implementing the trial. (c) 2006 Elsevier Inc. All rights reserved.

KW - randomised controlled trial

KW - cervical screening

KW - colposcopy

KW - cytological surveillance

KW - management

KW - low-grade abnormalities

KW - cervix uteri

KW - mild dyskaryosis

U2 - 10.1016/j.cct.2006.04.001

DO - 10.1016/j.cct.2006.04.001

M3 - Article

VL - 27

SP - 449

EP - 471

JO - Contemporary Clinical Trials

JF - Contemporary Clinical Trials

SN - 1551-7144

IS - 5

ER -